Heart is a frequent site of drug toxicity and assessing the safety of new drugs in in-vitro and in-vivo studies becomes crucial. Therefore, ensuring the safety of new medical entities is of paramount importance for the pharmaceutical industry. Cardiac safety concerns such as drug-induced heart rhythm abnormalities are among the key causes for promising drug failure or delay, causing loss of millions to the innovator or developer. This issue results in a lot of product recalls and pipeline attrition for pharmaceutical companies. To tackle these challenges and speed up development process, pharmaceutical companies are inclining towards the specialized service provider of cardiovascular safety studies.

Heart is a frequent site of drug toxicity and assessing the safety of new drugs in in-vitro and in-vivo studies becomes crucial. Therefore, ensuring the safety of new medical entities is of paramount importance for the pharmaceutical industry. Cardiac safety concerns such as drug-induced heart rhythm abnormalities are among the key causes for promising drug failure or delay, causing loss of millions to the innovator or developer. This issue results in a lot of product recalls and pipeline attrition for pharmaceutical companies. To tackle these challenges and speed up development process, pharmaceutical companies are inclining towards the specialized service provider of cardiovascular safety studies.

Increasing focus on of drug discovery and development, stringent regulatory guidelines for cardiac safety in drugs development and unavailability of cardiac safety experts in-house are some of the key factors driving the growth of this market. However, current cardiac safety platforms and services have several limitations and there remains persistent unmet need to improve the predictive power of present cardiac drug safety platforms and services. Hence, more accurate predictive models are needed and this holds and enormous opportunity for the players in this market.

The cardiac safety services market is segmented based on type, application, end user, and region. The cardiac safety services can either be integrated or standalone. Their applications include ECG measurement, QT studies, blood Pressure, cardiovascular Imaging and Others. Other applications include protocol design and expert reporting, scientific & regulatory expertise. Similarly, the key users for cardiac safety services includes pharmaceutical and biotechnology companies and contract research organizations.

The market by region is divided in four key geographies - North America, Europe, Asia-Pacific and rest of the World. North America is expected to dominate the market in 2018, with the US accounting for a major share. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period.